CAS 425613-09-8

Fórmula: C16H15FN2O4

InChI: InChI=1S/C16H15FN2O4/c1-2-11-3-6-13(7-4-11)23-10-16(20)18-12-5-8-14(17)15(9-12)19(21)22/h3-9H,2,10H2,1H3,(H,18,20)

Chave InChI: YSZJLXPXVFGTNK-UHFFFAOYSA-N

SMILES: CCC1=CC=C(C=C1)OCC(=O)NC2=CC(=C(C=C2)F)[N+](=O)[O-]

SJ000291942

CAS: 425613-09-8

SJ000291942

Fórmula: C₁₆H₁₅FN₂O₄

Pureza: 99.5%

Peso molecular: 318.3

Ref: 54-BUP05928

2-(4-Ethylphenoxy)-N-(4-fluoro-3-nitrophenyl)acetamide

CAS: 425613-09-8

Fórmula: C₁₆H₁₅FN₂O₄

Pureza: 99%

Cor e Forma: Solid

Peso molecular: 318.2997

Ref: IN-DA01EO6L

SJ000291942

CAS: 425613-09-8

SJ000291942 is an activator of the canonical bone morphogenetic proteins (BMP) signaling pathway.

Fórmula: C₁₆H₁₅FN₂O₄

Pureza: 99.66%

Cor e Forma: Solid

Peso molecular: 318.2997

Ref: TM-T4662

SJ000291942

CAS: 425613-09-8

2-(4-Ethylphenoxy)-N-(4-fluoro-3-nitrophenyl)acetamide

Fórmula: C₁₆H₁₅FN₂O₄

Pureza: 99%

Peso molecular: 318.3

Ref: IN-DG00816503

2-(4-Ethylphenoxy)-N-(4-fluoro-3-nitrophenyl)acetamide

CAS: 425613-09-8

Pureza: ≥99%

Peso molecular: 318.3039856

Ref: 10-F549508

SJ000291942

CAS: 425613-09-8

SJ000291942 is a drug that inhibits the growth of cancer cells in the laboratory. It has been shown to inhibit tumor formation and to prevent the development of metastases. SJ000291942 can be used to treat cancer by modulating neurological function, inhibiting cancer cell proliferation, and inducing apoptosis (programmed cell death). This drug binds to bone morphogenetic protein receptors and activates downstream signaling pathways that lead to cell death. SJ000291942 also has potent anti-inflammatory effects, as it decreases markers of inflammation such as IL-6, IL-1β, MMP-9, and TNF-α. It also increases markers of bone formation such as osteocalcin and osteoprotegerin.

Fórmula: C₁₆H₁₅FN₂O₄

Pureza: Min. 95%

Peso molecular: 318.3 g/mol

Ref: 3D-ASA61309